Alnylam Pharmaceuticals
ALNY
#446
Rank
โ‚ฌ44.73 B
Marketcap
338,65ย โ‚ฌ
Share price
-3.65%
Change (1 day)
45.01%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company